FLT3m+ AML
Session title: Satellite 3 – Astellas: Reshaping the Management of FLT3m+ AML
with New Targeted Agents
11:30 - 12:30, 30 January, 36th General Annual Meeting
Language: English
FLT3 Diagnostics: which Test for which Patients?
Session title: Satellite 3 – Astellas: Reshaping the Management of FLT3m+ AML
with New Targeted Agents
11:30 - 12:30, 30 January, 36th General Annual Meeting
Language: English
FLT3 Targeted Therapies (1st line and R/R)
Session title: Satellite 3 – Astellas: Reshaping the Management of FLT3m+ AML
with New Targeted Agents
11:30 - 12:30, 30 January, 36th General Annual Meeting
Language: English
Liquid Biopsies for Hodgkin and DLBCL (differential) Diagnosis
Laboratory Session at GAM 2021 in collaboration with the Belgian Society of Pathology
11:30 - 12:30, 30 January, 36th General Annual Meeting
Language: English
Which RIC for which AML Patient
Session title: Highlights on Malignant Hematology Part 2
10:30 - 11:00, 30 January, 36th General Annual Meeting
Language: English
MM and Immune Related Therapies
Session title: Highlights on Malignant Hematology Part 1
10:00 - 10:30, 30 January, 36th General Annual Meeting
Language: English
Can Novel Therapies Improve Outcomes for Patients with DLBCL?
Session title: Satellite 2 – Roche : What does the Future hold for Patients with DLBCL?
09:00 - 10:00, 30 January, 36th General Annual Meeting
Language: English
Treatment in very Elderly DLBCL Patients: Hopes and Caveats.
Session title: Satellite 2 – Roche : What does the Future hold for Patients with DLBCL?
09:00 - 10:00, 30 January, 36th General Annual Meeting
Language: English